Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 251,627,616
  • Shares Outstanding, K 5,952,865
  • Annual Sales, $ 52,546 M
  • Annual Income, $ 21,308 M
  • 36-Month Beta 0.87
  • Price/Sales 4.76
  • Price/Cash Flow 11.32
  • Price/Book 3.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.63
  • Number of Estimates 4
  • High Estimate 0.64
  • Low Estimate 0.63
  • Prior Year 0.62
  • Growth Rate Est. (year over year) +1.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.42 +4.00%
on 12/26/18
43.73 -3.88%
on 12/31/18
+0.10 (+0.25%)
since 12/21/18
3-Month
40.42 +4.00%
on 12/26/18
46.47 -9.54%
on 12/04/18
-2.06 (-4.68%)
since 10/23/18
52-Week
33.20 +26.61%
on 02/09/18
46.47 -9.54%
on 12/04/18
+5.22 (+14.16%)
since 01/23/18

Most Recent Stories

More News
The Zacks Analyst Blog Highlights: Pfizer, Biogen, Schwab, Sysco and Philips

The Zacks Analyst Blog Highlights: Pfizer, Biogen, Schwab, Sysco and Philips

SYY : 62.87 (+0.34%)
SCHW : 47.29 (-0.38%)
PFE : 42.03 (-0.57%)
PHG : 36.16 (+1.35%)
BIIB : 336.69 (-0.67%)
Caris Life Sciences Names Chief Communications Officer

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that Srikant (Sri) Ramaswami, has joined the company as Vice President...

JNJ : 128.55 (-0.19%)
PFE : 42.03 (-0.57%)
Top Stock Reports for Pfizer, Biogen & Schwab

Top Stock Reports for Pfizer, Biogen & Schwab

SYY : 62.87 (+0.34%)
SCHW : 47.29 (-0.38%)
CSX : 64.78 (-1.60%)
PHG : 36.16 (+1.35%)
PFE : 42.03 (-0.57%)
BIIB : 336.69 (-0.67%)
Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY

Pfizer's (PFE) tafamidis application gets FDA's priority review. Regulatory updates for Roche's (RHHBY) and Bristol-Myers'(BMY) cancer combination drugs in focus.

KTOV : 1.27 (-7.30%)
AZN : 36.59 (+0.88%)
LLY : 117.98 (+0.76%)
RHHBY : 32.5300 (+1.01%)
PFE : 42.03 (-0.57%)
BMY : 50.00 (+0.56%)
SNY : 41.77 (+0.67%)
Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress

The index enjoyed another strong week of gains, increasing over three straight sessions.

NFLX : 319.85 (-1.63%)
GOOGL : 1,079.93 (+0.12%)
AAPL : 152.93 (-0.24%)
JPM : 102.64 (-0.29%)
MRK : 75.31 (-0.69%)
MMM : 191.62 (-0.33%)
GS : 196.62 (-0.54%)
PFE : 42.03 (-0.57%)
UNH : 265.55 (-0.05%)
MSFT : 105.90 (+0.21%)
CAT : 131.50 (-0.56%)
WBA : 71.65 (+0.08%)
AXP : 99.21 (-0.62%)
AMZN : 1,633.26 (+0.07%)
BA : 357.17 (-0.20%)
Baxter (BAX) Gains From Sharesource's Global Success Rates

Baxter's (BAX) PD platform sees increased demand, owing to rising CKD rates around the world.

VEEV : 103.65 (+0.52%)
BAX : 69.39 (-0.39%)
PFE : 42.03 (-0.57%)
DVA : 56.95 (+0.18%)
J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect

J&J's (JNJ) Pharmaceuticals segment is likely to face difficult comparisons in fourth quarter.

RARE : 49.22 (-3.77%)
JNJ : 128.55 (-0.19%)
REGN : 399.95 (-1.19%)
PFE : 42.03 (-0.57%)
Ocular Inflammation Treatment Market is set to Grow US$ 500 Billion by 2024

New York, January 16, 2019: The is expected to exceed more than US$ 500 Billion by 2024 at a CAGR of 6% in the given forecast period.

VRX.TO : 30.80 (-3.33%)
ALIM : 0.86 (+1.87%)
AGN : 159.47 (+1.06%)
NVS : 88.25 (-0.08%)
AKRX : 3.82 (+4.09%)
PFE : 42.03 (-0.57%)
Pfizer (PFE) Gains But Lags Market: What You Should Know

Pfizer (PFE) closed at $42.73 in the latest trading session, marking a +0.85% move from the prior day.

PFE : 42.03 (-0.57%)
Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer

Bristol-Myers (BMY) gets EU approval for the immuno-oncology combination of Opdivo and low-dose Yervoy for the first-line treatment of patients with intermediate- and poor-risk advanced RCC.

CELG : 86.57 (+0.66%)
LLY : 117.98 (+0.76%)
PFE : 42.03 (-0.57%)
BMY : 50.00 (+0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade PFE with:

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

2nd Resistance Point 43.06
1st Resistance Point 42.66
Last Price 42.03
1st Support Level 41.90
2nd Support Level 41.54

See More

52-Week High 46.47
Last Price 42.03
Fibonacci 61.8% 41.40
Fibonacci 50% 39.83
Fibonacci 38.2% 38.27
52-Week Low 33.20

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar